share_log

Item 9 Labs (OTC:INLB) Shares Down 5.7%

Item 9 Labs (OTC:INLB) Shares Down 5.7%

Item 9 Labs(场外交易代码:INLB)股价下跌5.7%
Defense World ·  2022/12/14 01:52

Item 9 Labs Corp. (OTC:INLB – Get Rating)'s share price fell 5.7% on Tuesday . The company traded as low as $0.25 and last traded at $0.25. 33,714 shares traded hands during trading, an increase of 73% from the average session volume of 19,515 shares. The stock had previously closed at $0.27.

Item 9 Labs Corp.(场外交易代码:INLB — 获取评级)的股价周二下跌了5.7%。该公司的交易价格低至0.25美元,最后一次交易价格为0.25美元。交易期间有33,714股股票交易,较平均交易日交易量19,515股增长了73%。该股此前收于0.27美元。

Item 9 Labs Stock Down 5.7 %

Item 9 Labs 股票下跌 5.7%

The firm has a market cap of $24.42 million, a P/E ratio of -1.00 and a beta of 0.33. The business's fifty day moving average price is $0.30 and its two-hundred day moving average price is $0.53. The company has a current ratio of 0.14, a quick ratio of 0.04 and a debt-to-equity ratio of 0.02.

该公司的市值为2442万美元,市盈率为-1.00,beta值为0.33。该公司的五十天移动平均价格为0.30美元,其两百天移动平均线价格为0.53美元。该公司的流动比率为0.14,速动比率为0.04,债务与权益比率为0.02。

Item 9 Labs Company Profile

第 9 项 Labs 公司简介

(Get Rating)

(获取评分)

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.

Item 9 Labs Corp. 在美国是一家垂直整合的大麻运营商和药房特许经营商。该公司生产各种类别的大麻和大麻相关产品,例如花卉、浓缩物、馏出物和硬件。它通过持牌药房向亚利桑那州的消费者提供大麻和大麻衍生产品和技术。

See Also

另见

  • Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
  • We Are the Champions: 3 Dividend Growers Wall Street Loves
  • Will Nordstrom Stock be the Grinch This Year?
  • Harpoon Therapeutics Remains Volatile After Promising News
  • What is Market Structure in Trading?
  • Institutional Selling Is No Headwind For Nike
  • 免费获取 StockNews.com 关于 Item 9 Labs (INLB) 的研究报告的副本
  • 我们是冠军:华尔街最喜欢的 3 个股息种植者
  • 诺德斯特龙股票今年会成为格林奇吗?
  • 在有希望的消息传出后,Harpoon Therape
  • 什么是交易中的市场结构?
  • 机构抛售对耐克来说不是不利因素

Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Item 9 Labs 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Item 9 Labs及相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发